Skip to main content
. 2023 Mar 14;29(10):1569–1588. doi: 10.3748/wjg.v29.i10.1569

Figure 3.

Figure 3

Immune check point inhibitors treatment for metastatic colorectal cancer. CTLA4: Cytotoxic T-lymphocyte-associated protein 4; MHC: Major histocompatibility complex; PD-1: Programmed cell death protein 1; PD-L1: Programmed death-ligand; TCR: T cell receptor.